HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Luukkonen, B. G. M. Articles by Schwartz, S. Search for Related Content PubMed PubMed Citation Articles by Luukkonen, B. G. M. Articles by Schwartz, S. Agricola Articles by Luukkonen, B. G. M. Articles by Schwartz, S.

Analysis of cross reactivity of retrovirus proteases using a vaccinia virus-T7 RNA polymerase-based expression system

B. G. Mattias Luukkonen

Microbiology and Tumorbiology Center, Karolinska Institute, PO Box 280, S-171 77 Stockholm, Sweden

We have used the vaccinia virus-T7 RNA polymerase-based expression system for studies on the activity of proteases from various retroviruses on homologous and heterologous Gag polyproteins in eukaryotic cells. Proteases from human immunodeficiency virus (HIV) types 1 and 2, equine infectious anaemia virus, human T cell leukaemia virus type 1 and human spumavirus were produced and were shown to cleave their cognate Gag substrates produced in trans. Analysis of cross reactivity revealed that lentivirus proteases cleaved only lentivirus Gag proteins and oncovirus proteases acted primarily on oncovirus Gag proteins. The HIV-2 protease cleaved the HIV-1 Gag precursor almost as efficiently as HIV-1 protease. Expression of the 5' end of the human spumavirus pol gene revealed that it encodes a functional protease that acts specifically on the human spumavirus Gag polyprotein. This assay will allow further investigation on the activity and specificity of retrovirus proteases in eukaryotic cells.

^* Author for correspondence. Fax +46 8 331 399. e-mail stefan.schwartz@mtc.ki.se

Present address: European Molecular Biology Laboratory, Meyerhofstrasse 1, 69012 Heidelberg, Germany.

Received 5 January 1995; accepted 3 May 1995.

This article has been cited by other articles:

				T. Sperka, P. Boross, H. Eizert, J. Tozser, and P. Bagossi Effect of mutations on the dimer stability and the pH optimum of the human foamy virus protease Protein Eng. Des. Sel., August 1, 2006; 19(8): 369 - 375. [Abstract] [Full Text] [PDF]

				J. M. Louis, S. Oroszlan, and J. Tozser Stabilization from Autoproteolysis and Kinetic Characterization of the Human T-cell Leukemia Virus Type 1 Proteinase J. Biol. Chem., March 5, 1999; 274(10): 6660 - 6666. [Abstract] [Full Text] [PDF]

				A.-M. Vandamme, M. Salemi, M. Van Brussel, H.-F. Liu, K. Van Laethem, M. Van Ranst, L. Michels, J. Desmyter, and P. Goubau African Origin of Human T-Lymphotropic Virus Type 2 (HTLV-2) Supported by a Potential New HTLV-2d Subtype in Congolese Bambuti Efe Pygmies J. Virol., May 1, 1998; 72(5): 4327 - 4340. [Abstract] [Full Text] [PDF]